[1] 李薇,杨汀,王辰.中国慢性阻塞性肺疾病防治现状及进展[J].中国研究型医院,2020(05):1-5. [2] GOLD Executive Committee.Globle strategy for the diagnose,management,and prevention of chronic obstructive pulmonary disease(Revised2023)[EB/OL].[2022-02-15].https://goldcopd.org/2023-gold-report-2. [3] MACLEOD M,PAPI A,CONTOLI M,et al.Chronic obstructive pulmonary disease exacerbation fundamentals:Diagnosis,treatment,prevention and disease impact[J].Respirology(Carlton,Vic),2021,26(6):532-51. [4] SIDDIQUI S H,GUASCONI A,VESTBO J,et al.Blood Eosinophils:A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease[J].American journal of respiratory and critical care medicine,2015,192(4):523-5. [5] ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide,2005[J].American journal of respiratory and critical care medicine,2005,171(8):912-30. [6] RUPANI H,CHAUHAN A J.Measurement of FeNO in asthma:what the hospital doctor needs to know[J].British journal of hospital medicine(London,England:2005),2019,80(2):99-104. [7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南(2021年修订版)[J].中华结核和呼吸杂志,2021,(03):170-205. [8] CAI B Q,CAI S X,CHEN R C,et al.Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China[J].Int J Chron Obstruct Pulmon Dis,2014,9:381-95. [9] GEORGE L,BRIGHTLING C E.Eosinophilic airway inflammation:role in asthma and chronic obstructive pulmonary disease[J].Therapeutic advances in chronic disease,2016,7(1):34-51. [10] BAFADHEL M,PETERSON S,DE BLAS M A,et al.Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease:a post-hoc analysis of three randomised trials[J].Lancet Respir Med,2018,6(2):117-26. [11] GREULICH T,TüFFERS J,MAGER S,et al.High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients-a retrospective analysis[J].Respir Res,2020,21(1):106. [12] YUN J H,LAMB A,CHASE R,et al.Blood eosinophil count thresholdsBlood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease[J].The Journal of allergy and clinical immunology,2018,141(6):2037-47.e10. [13] BAFADHEL M,MCKENNA S,TERRY S,et al.Acute exacerbations of chronic obstructive pulmonary disease:identification of biologic clusters and their biomarkers[J].American journal of respiratory and critical care medicine,2011,184(6):662-71. [14] HARTJES F J,VONK J M,FAIZ A,et al.Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD[J].Respirology(Carlton,Vic),2018,23(11):1023-31. [15] PARK Y M,BOCHNER B S.Eosinophil survival and apoptosis in health and disease[J].Allergy,asthma & immunology research,2010,2(2):87-101. [16] PIGNATTI P,VISCA D,CHERUBINO F,et al.Do blood eosinophils strictly reflect airway inflammation in COPD Comparison with asthmatic patients[J].Respir Res,2019,20(1):145.
2024, Vol. 44 
